Clinical Trial Update: A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigates combination of duvelisib with SG001 injection in patients with advanced solid tumors (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Duvelisib (duvelisib)
• SG001

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN